BSc (Hons) MBChB (Hons)
Honorary Clinical Researcher
Josh’s academic interests include technological innovation, respiratory disease and evidence based medicine.
Research aims include developing a clinically relevant evidence base of novel technologies in a primary care setting.
Current projects include exploring the role of fractional exhaled nitric oxide (FeNO) in informing steroid management decisions in asthmatic patients. Josh is currently involved in two systematic reviews and a local project exploring the use of FeNO in informing the tapering or titration of inhaled corticosteroid therapy in asthmatic populations.